KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Net Income (2016 - 2025)

Historic Net Income for Pacific Biosciences Of California (PACB) over the last 16 years, with Q3 2025 value amounting to -$38.0 million.

  • Pacific Biosciences Of California's Net Income rose 3742.28% to -$38.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$503.6 million, marking a year-over-year decrease of 2774.81%. This contributed to the annual value of -$309.9 million for FY2024, which is 101.59% down from last year.
  • According to the latest figures from Q3 2025, Pacific Biosciences Of California's Net Income is -$38.0 million, which was up 3742.28% from -$41.9 million recorded in Q2 2025.
  • Over the past 5 years, Pacific Biosciences Of California's Net Income peaked at $16.5 million during Q3 2021, and registered a low of -$426.1 million during Q1 2025.
  • In the last 5 years, Pacific Biosciences Of California's Net Income had a median value of -$69.8 million in 2023 and averaged -$82.4 million.
  • In the last 5 years, Pacific Biosciences Of California's Net Income skyrocketed by 16977.39% in 2021 and then tumbled by 56530.65% in 2022.
  • Quarter analysis of 5 years shows Pacific Biosciences Of California's Net Income stood at -$69.3 million in 2021, then decreased by 21.72% to -$84.4 million in 2022, then grew by 2.8% to -$82.0 million in 2023, then soared by 102.89% to $2.4 million in 2024, then plummeted by 1702.7% to -$38.0 million in 2025.
  • Its Net Income was -$38.0 million in Q3 2025, compared to -$41.9 million in Q2 2025 and -$426.1 million in Q1 2025.